Mutual Of America Capital Management LLC Protagonist Therapeutics, Inc Transaction History
Mutual Of America Capital Management LLC
- $9.12 Billion
- Q4 2024
A detailed history of Mutual Of America Capital Management LLC transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Mutual Of America Capital Management LLC holds 9,027 shares of PTGX stock, worth $339,234. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,027
Previous 8,860
1.88%
Holding current value
$339,234
Previous $398,000
12.56%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PTGX
# of Institutions
246Shares Held
56.8MCall Options Held
71.7KPut Options Held
114K-
Farallon Capital Management LLC San Francisco, CA5.86MShares$220 Million1.32% of portfolio
-
Black Rock Inc. New York, NY5.76MShares$216 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.43MShares$204 Million3.89% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.22MShares$158 Million0.0% of portfolio
-
State Street Corp Boston, MA3.18MShares$120 Million0.01% of portfolio
About Protagonist Therapeutics, Inc
- Ticker PTGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,084,100
- Market Cap $1.84B
- Description
- Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...